In response to a nationwide statutory recall issued by the Drug Administration of Vietnam under the Ministry of Health, executive representatives from Pharmedic Pharmaceutical Medicinal Joint Stock Company have publicized an operational recovery roadmap to address the sub-standard batch of its Sodium Chloride 0.9% ophthalmic solution. Corporate management confirmed that Pharmedic has suspended all commercial distribution, sequestered the remaining affected inventory, and initiated formal notification protocols across its wholesale networks, retail pharmacies, and medical institutions. Furthermore, the manufacturer has deployed a comprehensive product exchange initiative, allowing consumers holding bottles from the designated batch to secure new replacements, with Pharmedic covering all logistical and transport expenses.
The technical specifications of the non-compliant pharmaceutical batch identify the following parameters:
-
Product Identity and Registration: Sodium Chloride 0.9% eye drops, carrying the marketing authorization number 893100060724.
-
Batch Identification: Lot number 10370725, manufactured on July 14, 2025, with an expiration date fixed for January 14, 2028.
-
Deficiency Profile: The formulation failed to satisfy mandatory quality testing criteria for solution clarity, resulting in a Class 3 regulatory violation order.
Clinical insights from ophthalmic specialists indicate that eye drops are subject to stringent sterile manufacturing protocols and rigorous oversight due to their direct administration onto highly sensitive ocular structures. While clarity deficits classified under Level 3 violations represent lower-risk aesthetic or sensory defects that do not present immediate or fatal systemic health hazards, they can still compromise product safety benchmarks. Using a compromised solution carries a calculated risk of inducing localized ocular stinging, temporary irritation, or burning sensations, and in severe instances, may escalate into tissue swelling, secondary bacterial infections, or structural corneal damage, particularly in pediatric demographics. Consequently, health authorities advise the public to cross-reference product batch numbers on existing household medical supplies to preserve personal visual health.